Hyperparathyroidism - cinacalcet

Summary

Cinacalcet is not generally recommended for treating people on dialysis who have hyperparathyroidism because of their kidney disease. However, it is recommended for people on dialysis who:

• have very high levels of parathyroid hormone in their blood that can't be lowered by other treatments, and
• cannot have an operation to remove the parathyroid glands (a parathyroidectomy), because of the risks involved.

People who do receive cinacalcet should have regular checks. Treatment should be stopped if the parathyroid hormone levels in their blood do not fall substantially within 4 months.

Documents

For healthcare professionals

• TA117 Hyperparathyroidism - cinacalcet: Guidance (MS Word format)
• TA117 Hyperparathyroidism - cinacalcet: Guidance
• TA117 Hyperparathyroidism - cinacalcet: Quick reference guide

For patients, carers and the public

• TA117 Hyperparathyroidism - cinacalcet: Understanding NICE guidance (MS Word format)
• TA117 Hyperparathyroidism - cinacalcet: Understanding NICE guidance

Background information

• None found

Implementing this guidance

Any further information NICE has produced to help the NHS implement this guideline locally is linked to below:

• TA117 Hyperparathyroidism - cinacalcet: Audit criteria
• Hyperparathyroidism - cinacalcet: Costing statement